- [Resource Hub](/) - [Blog](/?resource-type=blog-post#library) - Software-controlled, not software-locked: why the wording matters for protocol fidelity Blog · 4 min read · For Core Facility Directors # Software-controlled, not software-locked: why the wording matters for protocol fidelity Why "software-controlled" (not "software-locked") is the accurate description of Singulator protocol fidelity — and what that distinction means for core facilities and S10 grant reproducibility. Key takeaways - "Software-controlled" and "software-locked" are not synonyms — one describes reproducibility, the other implies a vendor-imposed ceiling. The architecture is the same; only the accurate word survives scrutiny. - The protocol lives in software, not in operator technique — a senior tech and a first-week trainee produce the same nuclei because neither one is making protocol decisions in the moment. - The protocol library evolves; it isn't frozen at purchase — new validated tissue types and optimizations ship to existing instruments on a normal release cadence. Closer to a smartphone OS than fixed firmware. - For core facilities and S10 grants, that's the reproducibility argument — the capital investment gets more capable over its life instead of depreciating into rigidity. A few months ago, in a sales conversation with a single-cell core director, a senior PCS product manager caught herself describing the Singulator as "software-locked." The director's body language shifted. The conversation cooled. When she asked him about it later, he was direct: "Software-locked sounds like I can't optimize it. Like I'm stuck with whatever decisions you made when you built the cartridge. If a tissue type doesn't work, am I just out of luck?" One word changed the value the director thought he was being sold. "Locked" implied rigidity. "Locked" implied loss of control. "Locked" implied that the institutional capability — the thing the core was buying for a multi-year lifecycle — would be capped by the vendor's release decisions. The product manager went back and changed every instance of "software-locked" to "software-controlled" in the next sales deck. The next conversations went differently. That difference is worth a few minutes of attention if you're a core director, an S10 grant writer, or anyone evaluating a multi-year capital purchase. ## What "software-controlled protocols" means at the architecture level The Singulator Platform runs nuclei-isolation protocols defined in software and executed by a single-use cartridge. The protocol — exactly which mechanical forces, exactly which timings, exactly which fluidic transitions — is specified by the instrument and the consumable, not by the operator's technique or judgment. That's the part that makes the prep reproducible across operators. A senior tech and a first-week trainee produce the same nuclei because neither one of them is making protocol decisions in the moment. The protocol is in the software. The key distinction The protocol isn't locked. It evolves. New tissue types get validated. New protocol options get released. Optimizations get pushed to existing instruments. The library of available protocols grows over time — and any installed Singulator runs the latest validated protocol for any tissue type the platform supports, the moment that protocol is released. The right mental model is closer to a smartphone OS than a fixed-firmware appliance. The instrument is the same; the software-defined behavior gets better. ## Why this matters for core facilities and S10 grants For a single-cell core that supports many PIs across many tissue types, the question isn't "does this instrument work for the workflow we have today" — it's "will it still work for the workflow we have in two years, when a new PI walks in with a tissue type we've never processed." A truly locked instrument is a multi-year bet on what the vendor decided to support at the time you signed the purchase order. That's a reasonable risk if the vendor's roadmap aligns with where your science is going. It's not a great risk if the science moves and the instrument doesn't. A software-controlled platform doesn't make that bet the same way. New tissue types are protocol additions, not hardware additions. If a PI brings a tissue type you haven't seen, you check whether a validated protocol exists for it. If one does, you run it. If one doesn't, you ask the vendor when one will be released — and the answer is usually "soon" because protocol expansion is a normal release cadence, not a major-version hardware refresh. For an S10 grant proposal, that's the reproducibility argument the review committee responds to. The capital investment isn't depreciating into rigidity. It's a platform that gets more capable over its life. ## What this looks like in practice Today, the Singulator Platform supports protocols across 80+ validated tissue types — fresh, frozen, OCT, and FFPE. That number wasn't where it started. Each tissue type is a validated protocol release; new types get added as the validation work completes. When you buy a Singulator today, you're buying access to today's tissue-type library AND every future protocol release that runs on the same hardware. The S200+ shipping today will run protocols that don't exist yet a year from now. That's not the same thing as "locked." ## A small wording change with practical consequences Core directors and S10 reviewers read instrument descriptions the way scientists read methods sections — looking for the constraints that aren't being disclosed. "Locked" reads as a constraint. It reads as a vendor-imposed ceiling on a multi-year capital purchase. "Software-controlled" reads as what the architecture actually delivers: protocol consistency and reproducibility across operators, without surrendering the ability to optimize or expand the tissue-type library over the instrument's lifetime. The phrasing has been updated everywhere in customer-facing PCS materials. The architecture didn't change. The description now matches what the platform actually does — and what a core director is actually buying. ### Evaluating for your core? 20 minutes with a PCS application scientist on your intake profile — your hardest tissue types, the FFPE submissions you're currently turning away, and where the Singulator fits your S10 grant cycle. [Talk to a Specialist](https://precisioncellsystems.com/request-a-quote/) [Request a Quote](https://precisioncellsystems.com/request-a-quote/) More in the Painless Nuclei series - [The Lowest Tissue Input for Nuclei Prep — and Why It Matters More Than Throughput](/resources/lowest-tissue-input-nuclei-prep-platform/) - [What "Fully Automated Nuclei Isolation" Actually Means — Across Fresh, Frozen & FFPE](/resources/fully-automated-nuclei-isolation-fresh-frozen-ffpe/) Note on wording This post intentionally uses "software-controlled" throughout, including in references to materials that may previously have used "software-locked." The architecture hasn't changed; the language has. For research use only. On this page - [What "software-controlled" means](#what-software-controlled-means) - [Why it matters for cores & S10 grants](#why-it-matters-for-cores) - [What this looks like in practice](#what-it-looks-like-in-practice) - [A small wording change](#a-small-wording-change) ### Evaluating a multi-year capital purchase? Walk through your core's hardest tissue types and S10 grant cycle with a PCS application scientist — before you commit to anything. [Talk to a Specialist](https://precisioncellsystems.com/request-a-quote/) [Back to all resources](/#library) ## Similar resources [Blog](/resources/fully-automated-nuclei-isolation-fresh-frozen-ffpe/) Singulator 100 Singulator 200 Singulator 200+ 2026 ### What "fully automated nuclei isolation" actually means — across fresh, frozen, and FFPE One software-controlled workflow from tissue to sequencing-ready nuclei, whatever you start with. Here's what "fully automated" rules out — and the hardest case that proves it. [Read Blog](/resources/fully-automated-nuclei-isolation-fresh-frozen-ffpe/) [Blog](/resources/lowest-tissue-input-nuclei-prep-platform/) Singulator 100 Singulator 200 Singulator 200+ 2026 ### The Lowest Tissue Input for Nuclei Prep — and Why It Matters More Than Throughput Why the minimum input a platform can run — 2 mg fresh/frozen, a 50 µm FFPE curl on the Singulator — is the most consequential spec for labs with scarce or irreplaceable samples, and matters more than throughput. [Read Blog](/resources/lowest-tissue-input-nuclei-prep-platform/) [Ebook](/resources/tissue-dissociation-protocol-guide/) Singulator 100 Singulator 200 Singulator 200+ 2026 ### Tissue Dissociation Guide The most comprehensive tissue dissociation reference available. Interactive protocols for single-cell isolation and nuclei extraction across 57+ tissue types with community and Singulator-optimized methods. [Read Ebook](/resources/tissue-dissociation-protocol-guide/) [App Note](https://precisioncellsystems.com/wp-content/uploads/2026/02/Singulator-Application-Note-Cell-Prep-and-Sequencing-Skin-and-Kidney-Cells-with-Parse-Evercode-WT.pdf) Singulator 100 Singulator 200 2026 ### Cell Prep and Sequencing Skin and Kidney Cells with Parse Evercode WT The Singulator platform paired with Parse Biosciences technology enables efficient single-cell isolation and sequencing from challenging tissue types, with high viability and robust cell yields suitable for downstream scRNA-seq analysis. [Download App Note](https://precisioncellsystems.com/wp-content/uploads/2026/02/Singulator-Application-Note-Cell-Prep-and-Sequencing-Skin-and-Kidney-Cells-with-Parse-Evercode-WT.pdf) [App Note](https://precisioncellsystems.com/wp-content/uploads/2026/03/Singulator-Application-Note-Single-Cell-Sequencing-of-Tumor-Infiltrating-Lymphocytes-in-Lung-Cancer-with-10x.pdf) Singulator 100 Singulator 200 2026 ### Single-Cell Sequencing of Tumor-Infiltrating Lymphocytes in Lung Cancer with 10x These data demonstrate the ability of the Singulator Platform to prepare single-cell suspensions for both positive selection by a cell surface marker and single-cell RNA sequencing. These methods enable researchers to identify genes of interest for potential therapeutic targets for anti-tumor response [Download App Note](https://precisioncellsystems.com/wp-content/uploads/2026/03/Singulator-Application-Note-Single-Cell-Sequencing-of-Tumor-Infiltrating-Lymphocytes-in-Lung-Cancer-with-10x.pdf) [App Note](https://precisioncellsystems.com/wp-content/uploads/2026/03/Singulator-Application-Note-Single-Nuclei-Sequencing-of-Mouse-Cerebellum.pdf) Singulator 100 Singulator 200 2026 ### Single-Nuclei Sequencing of Mouse Cerebellum with 10x The Singulator™ Platform provides a reproducible and precise method for isolating nuclei from complex tissues suitable for single-nuclei RNA sequencing. Our results demonstrate consistent nuclei yield and high-quality sequencing metrics across biological replicates, making it a reliable tool for neuroscientific research. The ability to produce high-quality nuclei with minimal variability enhances the accuracy of downstream snRNA analyses, facilitating deeper insights into normal biology and disease. Finally, the ability to identify rare cell types underscores the efficacy of the Singulator Platform in comprehensive cellular analysis, providing a detailed representation of the cellular landscape. [Download App Note](https://precisioncellsystems.com/wp-content/uploads/2026/03/Singulator-Application-Note-Single-Nuclei-Sequencing-of-Mouse-Cerebellum.pdf) [App Note](https://precisioncellsystems.com/wp-content/uploads/2026/02/Singulator-Application-Note-Singulator-Use-of-Nuclei-Debris-Removal-Reagent.pdf) Singulator 100 Singulator 200 2026 ### Singulator Use of Nuclei Debris Removal Reagent The presence of intracellular and extracellular debris in single-nucleus RNA sequencing can present a significant challenge in obtaining reliable and accurate results. However, the use of the Precision Cell Systems Nuclei Debris Removal Reagent can effectively improve the quality of the samples. Our evaluation of the Nuclei Debris Removal Reagent shows successful removal of debris from traditionally high-debris samples of brain and liver nuclei while delivering high quality single nuclei suspensions. The resulting samples are able to be run through microfluidic single nuclei sequencing platforms without issues of clogging or reduced data quality [Download App Note](https://precisioncellsystems.com/wp-content/uploads/2026/02/Singulator-Application-Note-Singulator-Use-of-Nuclei-Debris-Removal-Reagent.pdf) [Field Guide](/resources/brain-tissue-complexity-myelin-lipids-neuronal-nuclei/) Singulator 200+ 2026 ### Overcoming Brain Tissue Complexity: Myelin, Lipids, and Fragile Neuronal Nuclei Brain FFPE tissue creates unique nuclei isolation challenges. Myelin debris, lipid contamination, and fragile neuronal nuclei require controlled automated processing to preserve cell-type diversity for single-nucleus sequencing. [Read Field Guide](/resources/brain-tissue-complexity-myelin-lipids-neuronal-nuclei/) [Field Guide](/resources/brain-tumor-ffpe-surgical-resection-single-cell/) Singulator 200+ 2026 ### Brain Tumor FFPE Processing: From Surgical Resection to Single-Nucleus Insights Process brain tumor FFPE from surgical resections on the Singulator 200+. Preserve cancer cells and immune populations for snRNA-seq and spatial analysis. [Read Field Guide](/resources/brain-tumor-ffpe-surgical-resection-single-cell/) [Ebook](/resources/cold-case-files-neuroscience-ffpe/) Singulator 200+ 2026 ### Cold Case Files:The Brain's Embedded Evidence How the Singulator 200+ preserves fragile neuronal nuclei from irreplaceable postmortem brain tissue. Automated FFPE processing for Alzheimer's, brain tumors, and brain atlases. [Read Ebook](/resources/cold-case-files-neuroscience-ffpe/) [Field Guide](/resources/ffpe-neurodegenerative-disease-research-singulator/) Singulator 200+ 2026 ### FFPE Nuclei Extraction for Neurodegenerative Disease Research Extract nuclei from FFPE brain tissue for Alzheimer's, Parkinson's, and Lewy body research. Longitudinal cohorts, cell-type preservation, and disease staging on the Singulator 200+. [Read Field Guide](/resources/ffpe-neurodegenerative-disease-research-singulator/) [Field Guide](/resources/integrating-snrna-seq-spatial-transcriptomics-brain-ffpe/) Singulator 200+ 2026 ### Integrating snRNA-seq with spatial transcriptomics for brain mapping Pair spatial transcriptomics with snRNA-seq from the same FFPE brain block. Block allocation, platform selection, and nuclei quality for multi-omic brain studies. [Read Field Guide](/resources/integrating-snrna-seq-spatial-transcriptomics-brain-ffpe/)